Blog Archives

Great Lakes NeuroTechnologies Expands Patent Portfolio

VIEW PDF 12 SEPT 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) expanded its large patent portfolio covering deep brain stimulation (DBS) tuning to 11 issued patents (and 20 currently pending applications) when it was recently awarded Patent 9,717,920

Telehealth Management of Parkinson’s Disease Using Wearable Sensors: An Exploratory Study

Dustin A. Heldman; Denzil A. Harris; Timothy Felong; Kelly L. Andrzejewski; E. Ray Dorsey; Joseph P. Giuffrida; Barry Goldberg; Michelle A. Burack. Digit Biomark 2017;1:43–51

Reliability of Continuous Parkinson’s Assessment Using Wearables

Dustin Heldman, Enrique Urrea Mendoza, Nicola Mennucci , Carol Zimmerman, Joseph Giuffrida, Zoltan Mari, Michelle Burack, Fredy J. Revilla 69th Annual Meeting of the American Academy of Neurology, Boston, MA, 2017

Telehealth Management of Parkinson’s Disease Using Wearable Sensors: An Exploratory Study

Dustin Heldman, Denzil Harris, Timothy Felong, Kelly Andrzejewski, E. Ray Dorsey, Joseph Giuffrida, Barry Goldberg, Michelle Burack 69th Annual Meeting of the American Academy of Neurology, Boston, MA, 2017

Continuous Assessment of Levodopa Response in Parkinson’s Disease Using Wearable Motion Sensors

Christopher L. Pulliam;  Dustin A. Heldman; Elizabeth B. Brokaw; Thomas O. Mera; Zoltan K. Mari; Michelle A. Burack IEEE Trans Biomed Eng. 2018 Jan;65(1):159-164.

Great Lakes NeuroTechnologies Receives Two Deep Brain Stimulation Programming Patents

VIEW PDF 21 FEB 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has recently received two Deep Brain Stimulation (DBS) tuning patents. DBS is used on patients with Parkinson’s disease and other movement disorders to help mitigate their symptoms. 

Great Lakes NeuroTechnologies Awarded Deep Brain Stimulation Programming Patent

VIEW PDF 11 JAN 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has been awarded Patent 9,522,278 (Movement Disorder Therapy System and Methods of Tuning Remotely, Intelligently and/or Automatically) from the US Patent Office, the seventh patent awarded to

Effect of subthalamic stimulation on distal and proximal upper limb movements in Parkinson’s disease.

Tamás G, Kelemen A, Radics P, Valálik I, Heldman D, Klivényi P, Vécsei L, Hidasi E, Halász L, Kis D, Barsi P, Golopencza P, Erőss L. Brain Res. 2016 Oct 1;1648(Pt A):438-44. doi: 10.1016/j.brainres.2016.08.019. Epub 2016 Aug 16.

Great Lakes NeuroTech to collaborate with UCB on Wearables and Data Visualization Tools to help improve patient experiences for people with Parkinson’s Disease

VIEW PDF 26 SEPT 2016: Valley View, OH – Great Lakes NeuroTech (GLNT) today announced plans to collaborate with the pharmaceutical company UCB to provide individuals with Parkinson’s Disease (PD) and their clinicians with improved quantitative tools for assessing the

WhyNext?2016 Event Brings Parkinson’s Community Together with Great Lakes NeuroTech

VIEW PDF 31 AUG 2016: Valley View, OH – Great Lakes NeuroTech (GLNT) held their 5th annual WhyNext? Event on August 22 focusing on Parkinson’s Disease (PD). WhyNext? brought together the entire GLNT team of engineers, researchers, software developers, commercial